1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Pelthos Therapeutics Inc.

Pelthos Therapeutics Inc.

PTHS
Pelthos Therapeutics Inc.US flagNew York Stock Exchange American
25.88
USD
-0.12
- -
16.78MMarket Cap

Income Statement (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
17
+ Sales & Services Revenue
- -
- -
- -
- -
- -
17
- Cost of Revenue
- -
- -
- -
- -
- -
9
+ Cost of Goods & Services
- -
- -
- -
- -
- -
9
Gross Profit
- -
- -
- -
- -
- -
7
+ Other Operating Income
- -
- -
- -
- -
- -
- -
- Operating Expenses
2
1
2
7
8
40
+ Selling, General & Admin
1
1
2
4
6
37
+ Research & Development
- -
- -
- -
3
1
1
+ Other Operating Expense
- -
- -
- -
- -
- -
2
Operating Income (Loss)
-1
-1
-2
-7
-8
-32
- Non-Operating (Income) Loss
-1
- -
- -
1
- -
18
+ Interest Expense, Net
- -
- -
- -
1
- -
3
+ Interest Expense
- -
- -
- -
1
1
3
- Interest Income
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
-1
- -
- -
- -
- -
15
Pretax Income
-1
-1
-2
-7
-8
-51
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
-7
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-1
-1
-2
-7
-8
-43
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-1
-1
-2
-7
-8
-43
- Minority Interest
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-1
-2
-7
-8
-43
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-1
-1
-2
-7
-8
-43
EBIT
-1
-1
-2
-7
-8
-32
EBITDA
-1
-1
-2
-7
-8
-30
EBITDA Margin (%)
-677.16
- -
- -
- -
- -
-179.49
EBITA
-1
-1
-2
-7
-8
-32
Gross Margin (%)
100
- -
- -
- -
- -
44.24
Operating Margin (%)
-677.16
- -
- -
- -
- -
-193.09
Profit Margin (%)
-330.4
- -
- -
- -
- -
-257.93
Sales per Employee
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
2
Basic Weighted Avg Shares
1
1
1
1
1
2
Basic EPS, GAAP
-0.71
-1.03
-2.65
-12.8
-14.27
-23.04
Basic EPS from Cont Ops
-0.71
-1.03
-2.65
-12.8
-14.27
-23.04
Diluted Weighted Avg Shares
1
1
1
1
1
2
Diluted EPS, GAAP
-0.71
-1.03
-2.65
-12.8
-14.27
-23.04
Diluted EPS from Cont Ops
-0.71
-1.03
-2.65
-12.8
-14.27
-23.04

Balance Sheet (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Total Current Assets
- -
- -
- -
- -
1
53
+ Cash, Cash Equivalents & STI
- -
- -
- -
- -
1
18
+ Cash & Cash Equivalents
- -
- -
- -
- -
1
18
+ ST Investments
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
9
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
9
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
24
+ Raw Materials
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
17
+ Finished Goods
- -
- -
- -
- -
- -
7
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
- -
- -
- -
1
3
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
- -
77
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
13
+ Property, Plant & Equip
- -
- -
- -
- -
- -
14
- Accumulated Depreciation
- -
- -
- -
- -
- -
1
+ LT Investments & Receivables
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
- -
64
+ Total Intangible Assets
- -
- -
- -
- -
- -
64
+ Goodwill
- -
- -
- -
- -
- -
25
+ Other Intangible Assets
- -
- -
- -
- -
- -
39
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
- -
- -
Total Assets
- -
- -
- -
- -
1
130
+ Payables & Accruals
3
3
3
5
2
15
+ Accounts Payable
- -
3
3
5
2
3
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
3
- -
- -
- -
- -
12
+ ST Debt
- -
- -
1
1
2
1
+ ST Borrowings
- -
- -
1
1
2
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
1
+ Other ST Liabilities
- -
- -
- -
1
- -
10
+ Deferred Revenue
- -
- -
- -
- -
- -
1
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
1
- -
10
Total Current Liabilities
4
3
4
7
4
26
+ LT Debt
- -
- -
- -
- -
- -
34
+ LT Borrowings
- -
- -
- -
- -
- -
31
+ LT Finance Leases
- -
- -
- -
- -
- -
3
+ Other LT Liabilities
- -
1
- -
- -
- -
31
+ Accrued Liabilities
- -
- -
- -
- -
- -
1
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
1
- -
- -
- -
30
Total Noncurrent Liabilities
- -
1
- -
- -
- -
66
Total Liabilities
4
4
4
7
4
92
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
- -
- -
2
7
19
104
+ Common Stock
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
2
7
19
104
- Treasury Stock
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-4
-4
-6
-14
-21
-65
+ Other Equity
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-4
-4
-4
-6
-3
39
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
Total Equity
-4
-4
-4
-6
-3
39
Total Liabilities & Equity
- -
- -
- -
- -
1
130
Shares Outstanding
1
1
1
1
1
3
Number of Employees
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
3
Net Debt
- -
- -
- -
1
2
13
Net Debt to Equity
-6.76
- -
-13.09
-18.19
-61.64
34.64
Tangible Common Equity Ratio
-4,978.21
- -
-6,730.21
-6,685.91
-198.25
-38.15
Current Ratio
0.02
- -
0.01
0.01
0.34
2.05
Cash Conversion Cycle
- -
- -
- -
- -
- -
528.6

Cash Flow Statement (USD)

APIChat
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
+ Net Income
-1
-1
-2
-7
-8
-43
+ Depreciation & Amortization
- -
- -
- -
- -
- -
2
+ Non-Cash Items
- -
- -
- -
4
2
25
+ Stock-Based Compensation
- -
- -
- -
2
2
5
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
1
+ Other Non-Cash Adj
- -
- -
- -
3
- -
18
+ Chg in Non-Cash Work Cap
-3
-1
1
2
- -
-6
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
-16
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
2
+ (Inc) Dec in Prepaid Assets
- -
- -
- -
- -
-1
-1
+ Inc (Dec) in Accts Payable
-3
-1
1
2
1
8
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
2
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
-4
-2
-2
-1
-6
-23
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
-8
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
-8
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
6
- -
+ Increase in Capital Stock
- -
- -
- -
- -
6
- -
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
3
+ Cash from Divestitures
- -
- -
- -
- -
- -
3
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
- -
- -
-5
+ Dividends Paid
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
1
- -
18
+ Cash From Debt
- -
- -
- -
1
1
19
+ Repayments of Debt
- -
- -
- -
- -
- -
-1
+ Other Financing Activities
3
2
1
- -
- -
28
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
4
2
2
1
6
45
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
- -
- -
- -
- -
18
EBITDA
-1
-1
-2
-7
-8
-30
EBITDA Margin (%)
-677.16
- -
- -
- -
- -
-179.49
Free Cash Flow
-4
-2
-2
-1
-6
-31
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
-3
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-2
-1
- -
-5
-5
Free Cash Flow per Basic Share
-3.9
-2.76
-1.69
-1.7
-10.39
-16.27
Price/Free Cash Flow
- -
- -
- -
- -
- -
-3.99
Cash Flow to Net Income
5.49
2.68
0.64
0.13
0.73
0.52
Capital Expenditures
- -
- -
- -
- -
- -
-8